Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests.

Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021

Premium

Backed by large public companies and growing prospective data, the first molecular blood tests to screen for multiple cancers are approaching commercialization.

Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development

The company aims to use the methylation technology from its multi-cancer screening assay to detect minimal residual disease in early-stage cancer patients.

My Gene Counsel, Genomet Develop Decision Support Solution for Precision Cancer Care

The combined solution will give health systems access to real-time genetics expertise so they can integrate genetic test results into patients' care.

UK Launches Public-Private iDx-Lung Consortium to Improve Early Detection of Lung Cancers

The Universities of Southampton and Leeds will lead the project with participation from Johnson & Johnson, Roche, Oncimmune, BC Platforms, Inivata, and NHS England.

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.

Nov 24, 2020

Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves

Premium

Nov 23, 2020

Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

Premium

Nov 17, 2020

Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition

Nov 11, 2020

Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing

Nov 02, 2020

Regulatory Documents for Newly Approved Liquid Biopsy NGS Panels Detail Diverse Test Claims, Methods

Premium

Oct 27, 2020

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies

Oct 23, 2020

Melanoma Treatment Stage Affects Ability of Liquid Biopsy to Predict Immunotherapy Benefit

Premium

Oct 16, 2020

Disparity in Microsatellite Instability Testing Suggests Need to Close Socioeconomic Access Gaps

Premium

Oct 14, 2020

Inspirata Partners With Carebox Healthcare on Automated Cancer Clinical Trial Matching

Oct 14, 2020

NCI-MATCH Data Shows Value of Platform Trials for Patients With Rare Genomically Driven Cancers

Premium

Oct 08, 2020

Germline Genetic Testing After Tumor Sequencing Can Uncover Clinically Actionable Variants

Oct 06, 2020

Pediatric Cancer Program Uses Comprehensive Molecular Profiling to Match Patients to Therapies

Sep 18, 2020

MSK Clonal Hematopoiesis Clinic Aims to Drive New Strategies for Cancer Risk Assessment, Prevention

Premium

Sep 03, 2020

Invitae Launches Study to Explore Impact of Testing Guidelines on Prostate Cancer Patients' Outcomes

Aug 27, 2020

Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications

Aug 25, 2020

ESMO Recommendations Outline Use of Next-Gen Sequencing in Metastatic Cancer Patients

Jul 24, 2020

TMB Harmonization Effort Yields Calibration Method to Correct Inter-Assay Variation

Premium

Jul 20, 2020

BostonGene, NEC Partner to Analyze Cancer Patient Tumors, Improve Treatment Response

Jul 15, 2020

Canadian Consortium Launches C$2.6M Liquid Biopsy Initiative to Improve Targeted Cancer Treatment

Jul 10, 2020

Menu

Genomics: Clinical Implementation

Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021

Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development

My Gene Counsel, Genomet Develop Decision Support Solution for Precision Cancer Care

UK Launches Public-Private iDx-Lung Consortium to Improve Early Detection of Lung Cancers

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves

Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition

Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing

Regulatory Documents for Newly Approved Liquid Biopsy NGS Panels Detail Diverse Test Claims, Methods

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies

Melanoma Treatment Stage Affects Ability of Liquid Biopsy to Predict Immunotherapy Benefit

Disparity in Microsatellite Instability Testing Suggests Need to Close Socioeconomic Access Gaps

Inspirata Partners With Carebox Healthcare on Automated Cancer Clinical Trial Matching

NCI-MATCH Data Shows Value of Platform Trials for Patients With Rare Genomically Driven Cancers

Germline Genetic Testing After Tumor Sequencing Can Uncover Clinically Actionable Variants

Pediatric Cancer Program Uses Comprehensive Molecular Profiling to Match Patients to Therapies

MSK Clonal Hematopoiesis Clinic Aims to Drive New Strategies for Cancer Risk Assessment, Prevention

Invitae Launches Study to Explore Impact of Testing Guidelines on Prostate Cancer Patients' Outcomes

Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications

ESMO Recommendations Outline Use of Next-Gen Sequencing in Metastatic Cancer Patients

TMB Harmonization Effort Yields Calibration Method to Correct Inter-Assay Variation

BostonGene, NEC Partner to Analyze Cancer Patient Tumors, Improve Treatment Response

Canadian Consortium Launches C$2.6M Liquid Biopsy Initiative to Improve Targeted Cancer Treatment

Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer